Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma DOI Creative Commons

Yueyue Fan,

Yuexin Cui,

Wenyan Hao

и другие.

Bioactive Materials, Год журнала: 2021, Номер 6(12), С. 4402 - 4414

Опубликована: Май 1, 2021

Nanosuspensions, as a new drug delivery system for insoluble drugs, are only composed of and small amount stabilizer, which is dispersed in an aqueous solution with high drug-loading, particle size, dispersion, large specific surface area. It can significantly improve the dissolution, bioavailability, efficacy drugs. In this study, paclitaxel nanosuspensions ((PTX)NS) were prepared by ultrasonic precipitation method, characteristics simple preparation easy repetition. With help homologous targeting mechanism, kind glioma C6 cancer cell membrane (CCM)-coated (PTX)NS was developed modified DWSW peptide to obtain DWSW-CCM-(PTX)NS functions BBB penetration tumor targeting. The results showed that could effectively camouflage so it not cleared immune cross blood-brain-barrier (BBB) selectively target tissues. Cell uptake experiments vivo imaging confirmed cells distribution intracranial gliomas increased. Cytotoxicity test anti-glioma studies inhibit growth prolong survival time glioma-bearing mice. Finally, coating endowed biological properties adhesion escape. This study provides integrated improving demonstrates encouraging potential biomimetic applicable therapy.

Язык: Английский

Self-Protecting Biomimetic Nanozyme for Selective and Synergistic Clearance of Peripheral Amyloid-β in an Alzheimer’s Disease Model DOI
Mengmeng Ma, Zhenqi Liu, Nan Gao

и другие.

Journal of the American Chemical Society, Год журнала: 2020, Номер 142(52), С. 21702 - 21711

Опубликована: Дек. 16, 2020

Clearance of peripheral amyloid-β (Aβ) has been demonstrated to be promising for overcoming the blood–brain barrier (BBB) hurdle eliminate brain-derived Aβ associated with Alzheimer's disease (AD). Even so, current developed therapeutic assays clearance are still facing challenges on how avoid interference certain biological molecules and prevent triggering activation immune responses blood clotting. Here, a biomimetic nanozyme (CuxO@EM-K) augmented protein adsorption resistance, minimized immunogenicity, enhanced biocompatibility is designed synthesized. The CuxO@EM-K made CuxO wrapped modified 3xTg-AD mouse erythrocyte membrane Aβ-targeting pentapeptide KLVFF. KLVFF serves as Aβ-specific ligand that works together selectively capture in blood. Meanwhile, coating prevents coronas formation thus retains ability fluids. More importantly, core multiple antioxidant enzyme-like activities stabilizes outer simultaneously mitigates Aβ-induced oxidative damage, which enables extended systemic circulation indispensable adsorbing Aβ. In vivo studies demonstrate not only reduces burden brain but also ameliorates memory deficits widely used model. Moreover, shows no apparent toxicity mice. Overall, this work provides an example developing biocompatible synergistic AD.

Язык: Английский

Процитировано

138

Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy DOI
Zhaoting Li, Yixin Wang,

Yingyue Ding

и другие.

Advanced Functional Materials, Год журнала: 2021, Номер 31(23)

Опубликована: Март 25, 2021

Abstract Immunotherapy is leading a paradigm shift in the treatment of various diseases, including tumors, auto‐immune and infectious diseases. However, limited response rate systemic side effects significantly impede clinical applications immunotherapy. As natural carriers for proteins molecules, cells with low immunogenicity toxicity have attracted considerable attention biomedical achieved encouraging progress especially The convergence multiple disciplines has equipped cell‐based delivery systems control over their spatiotemporal distribution to enhance efficacy reduce effects. Here, an overview fundamentals design principles followed by perspective that includes most recent advances as carriers, special focus on implications immunotherapy offered.

Язык: Английский

Процитировано

106

Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy DOI
Zahid Hussain, Muhammad Abdur Rahim, Nasrullah Jan

и другие.

Journal of Controlled Release, Год журнала: 2021, Номер 335, С. 130 - 157

Опубликована: Май 17, 2021

Язык: Английский

Процитировано

97

Recent Advances in Stimulus‐Responsive Nanocarriers for Gene Therapy DOI
Yu Cheng, Long Li, Pei Hu

и другие.

Advanced Science, Год журнала: 2021, Номер 8(14)

Опубликована: Май 16, 2021

Abstract Gene therapy provides a promising strategy for curing monogenetic disorders and complex diseases. However, there are challenges associated with the use of viral delivery vectors. The advent nanomedicine represents quantum leap in application gene therapy. Recent advances stimulus‐responsive nonviral nanocarriers indicate that they efficient systems loading unloading therapeutic nucleic acids. Some responsive to cues derived from internal environment, such as changes pH, redox potential, enzyme activity, reactive oxygen species, adenosine triphosphate, hypoxia. Others external stimulations, including temperature gradients, light irradiation, ultrasonic energy, magnetic field. Multiple stimuli‐responsive strategies have also been investigated recently experimental

Язык: Английский

Процитировано

97

Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma DOI Creative Commons

Yueyue Fan,

Yuexin Cui,

Wenyan Hao

и другие.

Bioactive Materials, Год журнала: 2021, Номер 6(12), С. 4402 - 4414

Опубликована: Май 1, 2021

Nanosuspensions, as a new drug delivery system for insoluble drugs, are only composed of and small amount stabilizer, which is dispersed in an aqueous solution with high drug-loading, particle size, dispersion, large specific surface area. It can significantly improve the dissolution, bioavailability, efficacy drugs. In this study, paclitaxel nanosuspensions ((PTX)NS) were prepared by ultrasonic precipitation method, characteristics simple preparation easy repetition. With help homologous targeting mechanism, kind glioma C6 cancer cell membrane (CCM)-coated (PTX)NS was developed modified DWSW peptide to obtain DWSW-CCM-(PTX)NS functions BBB penetration tumor targeting. The results showed that could effectively camouflage so it not cleared immune cross blood-brain-barrier (BBB) selectively target tissues. Cell uptake experiments vivo imaging confirmed cells distribution intracranial gliomas increased. Cytotoxicity test anti-glioma studies inhibit growth prolong survival time glioma-bearing mice. Finally, coating endowed biological properties adhesion escape. This study provides integrated improving demonstrates encouraging potential biomimetic applicable therapy.

Язык: Английский

Процитировано

95